Amgen’s $150 million investment aims to scale, diversify middle-market business

By Mark Alfred Special to the Business Times Thousand Oaks-based Amgen, one of the largest biotechnology companies in the world, invested $150 million into Project Black: an Ariel Investments fund intended to transform middle-market companies into certified minority-owned business enterprises. The fund, managed by Ariel’s private equity subsidiary Ariel Alternatives, is based in Chicago. It Read More →
Atara’s cuts down net loss in 2022

Atara Biotherapeutics recorded a lower net loss in the fourth quarter and the entirety of fiscal year 2022, but missed expectations still led to an 8% decline in after-hours trading. Atara, a South San Francisco-based immunotherapy company with its major operations in Thousand Oaks, reported a net loss of $228.3 million, or 2.24 cents per Read More →
Deckers races past third-quarter expectations behind strong Hoka sales

Deckers’ attempt to turn its running shoe brand, Hoka One One, into a billion-dollar blockbuster keeps panning out with each quarter that passes. The Goleta-based company again outpaced analysts’ expectations, this time for the third quarter of 2022, as revenue and earnings both shot up thanks in large part to the continuing growth of the Read More →
American Riviera notes rising net income for 2022

American Riviera Bancorp reported a net income of $13.5 million or $2.37 per share for fiscal year 2022 a rise from $11.8 million or $2.09 per share for the same time period last year. The increase in net income in 2022 as compared to 2021 is mostly due to loan growth, increased interest income on Read More →
Community West Bancshares nets record earnings

Community West Bancshares reported a record net income of $13.4 million or $1.51 per share in fiscal year 2022, the firm said in its earnings announcement on Jan. 27. The company’s board of directors also declared an increase of its quarterly cash dividend by 6.7% to $0.08 per common share, payable on Feb. 28 to Read More →